相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Current drug withdrawal strategy in prolactinoma patients treated with cabergoline: a systematic review and meta-analysis
Jintao Hu et al.
PITUITARY (2015)
Challenges and pitfalls in the diagnosis of hyperprolactinemia
Lucio Vilar et al.
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2014)
A Cross-Sectional Study of the Prevalence of Cardiac Valvular Abnormalities in Hyperprolactinemic Patients Treated With Ergot-Derived Dopamine Agonists
W. M. Drake et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Second attempt to withdraw cabergoline in prolactinomas: a pilot study
Ratchaneewan Kwancharoen et al.
PITUITARY (2014)
Cabergoline treatment in acromegaly: pros
Monica Marazuela et al.
ENDOCRINE (2014)
Safety of long-term treatment with cabergoline on cardiac valve disease in patients with prolactinomas
Renata S. Auriemma et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Cabergoline use and risk of fibrosis and insufficiency of cardiac valves Meta-analysis of observational studies
R. De Vecchis et al.
HERZ (2013)
Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment
Atanaska Elenkova et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: a single center experience
Panagiotis Anagnostis et al.
PITUITARY (2012)
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
Shlomo Melmed et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
BMI and Metabolic Profile in Patients With Prolactinoma Before and After Treatment With Dopamine Agonists
Cintia M. dos Santos Silva et al.
OBESITY (2011)
Update on the withdrawal of dopamine agonists in patients with hyperprolactinemia
Alberto M. Pereira
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2011)
Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)
Alberto Fernandez et al.
CLINICAL ENDOCRINOLOGY (2010)
Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis
Olaf M. Dekkers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Prolactinomas
Anne Klibanski
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Management of prolactinomas in Brazil: an electronic survey
Lucio Vilar et al.
PITUITARY (2010)
The prolactinoma
Annamaria Colao
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Recurrence of Hyperprolactinemia after Withdrawal of Long-Term Cabergoline Therapy
J. Kharlip et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Treatment with low doses of cabergoline is not associated with increased prevalence of cardiac valve regurgitation in patients with hyperprolactinaemia
F. Bogazzi et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Increased prevalence of tricuspid regurgitation in patients with Prolactinomas chronically treated with cabergoline
Annamaria Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Diagnosis and management of hyperprolactinemia:: Results of a Brazilian multicenter study with 1234 patients
L. Vilar et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2008)
Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy
Annamaria Colao et al.
CLINICAL ENDOCRINOLOGY (2007)
High prevalence of pituitary adenomas: A cross-sectional study in the province of Liege, Belgium
Adrian F. Daly et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Valvular heart disease in Parkinson's disease vs. controls:: An echocardiographic study
Cecilia Peralta et al.
MOVEMENT DISORDERS (2006)
Advances in the treatment of prolactinomas
Mary P. Gillam et al.
ENDOCRINE REVIEWS (2006)
Long-term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomas
M Biswas et al.
CLINICAL ENDOCRINOLOGY (2005)
Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia
A Colao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
